MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0010040
Cadmic Pharmaceuticals Private Limited
Cadmic Pharmaceuticals Private Limited - trading in Panchkula, Haryana, India. Directors, charges & compliance details.
Revenue · FY 2022
₹4.69 Lakh
Latest filing
Net loss · FY 2022
₹3.3 Lakh
Net margin -70.4%
EBITDA · FY 2022
-₹3.29 Lakh
EBITDA margin -70.1%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Cadmic Pharmaceuticals Private Limited
Data last updated:
Cadmic Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 08 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2020PTC089129. Its GSTIN is 06AAICC9553F1ZI (Haryana).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Surinder Kumar Verma (Managing Director) and Mukesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at House No. 398 Near Sunaro Wala Mohala Barwala(246), Panchkula, Haryana, India – 134118.
As per the financials filed for FY 2022, the company reported a revenue of ₹4.69 Lakh. For the same year it recorded a net loss of ₹3.3 Lakh (net margin -70.4%) and EBITDA of -₹3.29 Lakh (EBITDA margin -70.1%).
Cadmic Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0010040).
Company details
CIN U51909HR2020PTC089129
Registration Number 089129
Incorporation Date 08 September 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0010040
Recognitions & Rankings of Cadmic Pharmaceuticals
Contact details
Cadmic Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressHouse No. 398 Near Sunaro Wala Mohala Barwala(246), Panchkula, Haryana, India – 134118
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Cadmic Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cadmic Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cadmic Pharmaceuticals Private Limited, buy the company report.
Financials of Cadmic Pharmaceuticals Private Limited
FY 2022 filings availableCadmic Pharmaceuticals Private Limited reported revenue of ₹4.69 Lakh for FY 2022.
Revenue · FY 2022
₹4.69 Lakh
Net loss · FY 2022
₹3.3 Lakh margin -70.4%
EBITDA · FY 2022
-₹3.29 Lakh margin -70.1%
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹3.29 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹3.3 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -70.1% | |
| Net Profit Margin | -70.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Cadmic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cadmic Pharmaceuticals Private Limited
Cadmic Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar | Additional Director | 02 Jul 2021 | 5 Years 3 Months | Current |
| Surinder Kumar Verma | Managing Director | 08 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Cadmic Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cleancare Pharmaceuticals Private Limited | ₹4.7 Lakh (FY 2021) | Delhi, India | ||||
| Grey Mark Pharmaceuticals Private Limited | ₹4.69 Lakh (FY 2018) | Mumbai, Maharashtra, India | ||||
| Elanz Pharmaceuticals Private Limited | ₹4.69 Lakh (FY 2025) | -65.0% | Ahmedabad, Gujarat, India | |||
| Cadmic Pharmaceuticals Private Limitedthis company | ₹4.69 Lakh (FY 2022) | -₹3.3 Lakh | -70.4% | Panchkula, Haryana, India | ||
| Bevan Pharmaceuticals Private Limited | ₹4.68 Lakh (FY 2024) | -39.0% | Patna, Bihar, India |
To see the full peer comparison of Cadmic Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cadmic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cadmic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cadmic Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICC9553F1ZI | Haryana | Active | 28 Sep 2020 |
To see the full GST registrations and return filing status of Cadmic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cadmic Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Akin Verma ceased to be Director on 02 Jul 2021.
AGM
Cadmic Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Cadmic Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Haryana.
Ceased
Akin Verma ceased to be Director.
Appointed
Mukesh Kumar was appointed as Additional Director.
Appointed
Surinder Kumar Verma was appointed as Managing Director.
Incorporation
08 Sep 2020
Cadmic Pharmaceuticals Private Limited was registered on 08 Sep 2020 with Roc Haryana & aged 6 years 1 month as per MCA records.
Frequently asked questions
Cadmic Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in specialty, within the trading industry. It was incorporated on 08 September 2020 (6+ years old) and is registered under CIN U51909HR2020PTC089129.
Cadmic Pharmaceuticals has 2 current directors:
- Surinder Kumar Verma - Managing Director
- Mukesh Kumar - Additional Director
The latest financial statements of Cadmic Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Cadmic Pharmaceuticals is 06AAICC9553F1ZI, registered in Haryana.
The CIN (Corporate Identification Number) of Cadmic Pharmaceuticals is U51909HR2020PTC089129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cadmic Pharmaceuticals was incorporated on 08 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Cadmic Pharmaceuticals by revenue are Cleancare Pharmaceuticals Private Limited, Grey Mark Pharmaceuticals Private Limited, Elanz Pharmaceuticals Private Limited, Bevan Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Akin Verma ceased to be Director on 02 Jul 2021. Mukesh Kumar was appointed as Additional Director on 02 Jul 2021. Surinder Kumar Verma was appointed as Managing Director on 08 Sep 2020.
Yes, Cadmic Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0010040).
The registered office of Cadmic Pharmaceuticals is at House No. 398 Near Sunaro Wala Mohala Barwala246, Panchkula, Haryana, India – 134118.
Cadmic Pharmaceuticals operates in the trading industry, in the specialty segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages